IMO Health, Redox partner to boost healthcare data standardization

Redox will leverage IMO Precision Normalize to accelerate healthcare data standardization for its hospital and software vendor clients.
Published October 19, 2022
Written by
Picture of IMO Health
Staff

IMO Health recently announced a partnership with Wisconsin-based Redox to standardize clinical data from diverse systems. The partnership enables healthcare companies to spend more time building improved patient and clinician experiences by eliminating the lengthy and taxing process of combining multiple point solutions.

“Clinical patient data is a powerful resource in healthcare. IMO Health partnering with Redox will accelerate the ability for healthcare companies to leverage that data to create better outcomes for doctors and patients,” said IMO Health CEO Ann Barnes.

This collaboration is exciting for health IT because it helps to address growing data quality issues throughout the industry. While the amount of healthcare data is enormous and expanding, poor data quality can limit the potential of rapidly advancing technology. Rather than spending significant time, effort, and cost to improve the usability of this data, companies can now work with the tools that were designed to address this burden.

Read more about IMO Health and Redox’s partnership here.

Related Content

Blog digest signup

Resources sent straight to your inbox.

Latest Resources​

The addition of USCDI V3 and V4 to IMO Health’s proprietary lexicon ensures health systems comply with rapidly evolving regulations, avoiding costly...
Article
The U.S. government uses the National Drug Code (NDC) to identify and track drugs intended for human use. Get up to speed...
Ambient intelligence tools are skilled at recording patient-provider encounters in real-time. But can they truly understand them?
ICYMI: BLOG DIGEST

The latest insights and expert perspectives from IMO Health

In your inbox, twice per month.